000			01943 a2200529 4500
005			20250515013226.0
264		0	_c20060816
008			200608s 0 0 eng d
022			_a1545-5009
024	7		_a10.1002/pbc.20713 _2doi
040			_aNLM _beng _cNLM
100	1		_aJarrar, Mohammad
245	0	0	_aAsparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941). _h[electronic resource]
260			_bPediatric blood & cancer _cAug 2006
300			_a141-6 p. _bdigital
500			_aPublication Type: Clinical Conference; Journal Article
650	0	4	_aAntibody Formation _xdrug effects
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAsparaginase _xadministration & dosage
650	0	4	_aAsparagine _xdrug effects
650	0	4	_aChild
650	0	4	_aFemale
650	0	4	_aGlutamic Acid _xdrug effects
650	0	4	_aHumans
650	0	4	_aInjections, Intramuscular
650	0	4	_aMale
650	0	4	_aPolyethylene Glycols _xadministration & dosage
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aStatistics, Nonparametric
700	1		_aGaynon, Paul S
700	1		_aPericlou, Antonia P
700	1		_aFu, Cecilia
700	1		_aHarris, Richard E
700	1		_aStram, Daniel
700	1		_aAltman, Arnold
700	1		_aBostrom, Bruce
700	1		_aBreneman, John
700	1		_aSteele, David
700	1		_aTrigg, Michael
700	1		_aZipf, Theodore
700	1		_aAvramis, Vassilios I
773	0		_tPediatric blood & cancer _gvol. 47 _gno. 2 _gp. 141-6
856	4	0	_uhttps://doi.org/10.1002/pbc.20713 _zAvailable from publisher's website
999			_c16040947 _d16040947